# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.93) per share which missed the analyst consensus estimate of $(0.06...
Evoke Pharma shares were trading lower by 21.4% during Tuesday's session. The company announced a 1-for-12 reverse stock sp...
Common Stock To Trade On Split-Adjusted Basis Under Symbol EVOK With New CUSIP 30049G302
Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024Promoted former VP...
Evoke Pharma, Inc.(NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) d...